Showing results (81-90 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|April 1, 1996
Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksC L Chen, Q Liu, M V RellingPharmacogenetics|August 1, 1997
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholismU Finckh, H Rommelspacher, S Kuhn, et al.Pharmacogenetics|April 20, 1999
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populationsE S Collie-Duguid, S C Pritchard, R H Powrie, et al.Pharmacogenetics|April 20, 1999
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylationH J Gill, J F Tjia, N R Kitteringham, et al.Pharmacogenetics|April 20, 1999
Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site regionC Deng, D Xie, H Capasso, et al.Pharmacogenetics|February 18, 1999
Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like geneL A Trepanier, A E Cribb, S P Spielberg, et al.Pharmacogenetics|February 24, 2001
Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoterP A Gregory, A J Hansen, P I MackenziePharmacogenetics|March 27, 2001
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestryM Dettling, R T Schaub, B Mueller-Oerlinghausen, et al.Pharmacogenetics|February 24, 2001
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significanceK J Aitchison, F J Gonzalez, L C Quattrochi, et al.Pageof 83